Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy

Neuroscience

Volumn 199, Issue , 2011, Pages 401-409

  Pesaresi, M ^a   Giatti, S ^a   Cavaletti, G ^b   Abbiati, F ^a   Calabrese, D ^a   Lombardi, R ^c   Bianchi, R ^c   Lauria, G ^c   Caruso, D ^a   Garcia Segura, L M ^d   Melcangi, R C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d INSTITUTO CAJAL   (Spain)

Author keywords

Liquid chromatography tandem mass spectrometry; Myelin proteins; Neuroactive steroids; Peripheral nerve; Rat; Streptozotocin

Indexed keywords

17ALPHA ESTRADIOL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANDROSTANEDIOL; ESTRADIOL; MYELIN AND LYMPHOCYTE ASSOCIATED PROTEIN; MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22; PRASTERONE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; HEAT SENSITIVITY; MALE; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SEX DIFFERENCE; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

ANIMALS; DEHYDROEPIANDROSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FEMALE; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SEX CHARACTERISTICS;

EID: 83055188004     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.09.013     Document Type: Article

References (36)

1. Aaberg M.L., Burch D.M., Hud Z.R., Zacharias M.P. Gender differences in the onset of diabetic neuropathy. J Diabetes Complications 2008, 22:83-87.
2. Albers J.W., Brown M.B., Sima A.A., Greene D.A. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996, 46:85-91.
3. Basit A., Hydrie M.Z., Hakeem R., Ahmedani M.Y., Masood Q. Frequency of chronic complications of type II diabetes. J Coll Physicians Surg Pak 2004, 14:79-83.
4. Bergeron R., de Montigny C., Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 1996, 16:1193-1202.
5. Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., Lauria G., Borgna M., Lombardi R., Cimen B., Comelekoglu U., Kanik A., Tataroglu C., Cerami A., Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A 2004, 101:823-828.
6. Bianchi R., Marini P., Merlini S., Fabris M., Triban C., Mussini E., Fiori M.G. ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes 1988, 37:1340-1345.
7. Booya F., Bandarian F., Larijani B., Pajouhi M., Nooraei M., Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol 2005, 5:24.
8. Brown M.J., Bird S.J., Watling S., Kaleta H., Hayes L., Eckert S., Foyt H.L. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care 2004, 27:1153-1159.
9. Caruso D., Scurati S., Maschi O., De Angelis L., Roglio I., Giatti S., Garcia-Segura L.M., Melcangi R.C. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int 2008, 52:560-568.
10. Cermenati G., Giatti S., Cavaletti G., Bianchi R., Maschi O., Pesaresi M., Abbiati F., Volonterio A., Saez E., Caruso D., Melcangi R.C., Mitro N. Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy. J Neurosci 2010, 30:11896-11901.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
12. Demirgören S., Majewska M.D., Spivak C.E., London E.D. Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 1991, 45:127-135.
13. Fex Svenningsen A., Kanje M. Estrogen and progesterone stimulate Schwann cell proliferation in a sex- and age-dependent manner. J Neurosci Res 1999, 57:124-130.
14. Garcia-Segura L.M., Melcangi R.C. Steroids and glial cell function. Glia 2006, 54:485-498.
15. Giatti S., Pesaresi M., Cavaletti G., Bianchi R., Carozzi V., Lombardi R., Maschi O., Lauria G., Garcia-Segura L.M., Caruso D., Melcangi R.C. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience 2009, 164:520-529.
16. Kiziltan M.E., Gunduz A., Kiziltan G., Akalin M.A., Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. J Neurol Sci 2007, 258:75-79.
17. Lauria G., Lombardi R., Borgna M., Penza P., Bianchi R., Savino C., Canta A., Nicolini G., Marmiroli P., Cavaletti G. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 2005, 10:202-208.
18. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007, 144:1293-1304.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
20. Lu S.F., Mo Q., Hu S., Garippa C., Simon N.G. Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity. J Neurobiol 2003, 57:163-171.
21. Mehta A.K., Ticku M.K. An update on GABAA receptors. Brain Res Brain Res Rev 1999, 29:196-217.
22. Melcangi R.C., Garcia-Segura L.M. Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Horm Behav 2010, 57:2-11.
23. Melcangi R.C., Garcia-Segura L.M., Mensah-Nyagan A.G. Neuroactive steroids: state of the art and new perspectives. Cell Mol Life Sci 2008, 65:777-797.
24. Mo Q., Lu S., Garippa C., Brownstein M.J., Simon N.G. Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus. J Steroid Biochem Mol Biol 2009, 114:135-143.
25. Mo Q., Lu S.F., Hu S., Simon N.G. DHEA and DHEA sulfate differentially regulate neural androgen receptor and its transcriptional activity. Brain Res Mol Brain Res 2004, 126:165-172.
26. Mo Q., Lu S.F., Simon N.G. Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. J Steroid Biochem Mol Biol 2006, 99:50-58.
27. Monnet F.P., Mahé V., Robel P., Baulieu E.E. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A 1995, 92:3774-3778.
28. Pesaresi M., Giatti S., Cavaletti G., Abbiati F., Calabrese D., Bianchi R., Caruso D., Garcia-Segura L.M., Melcangi R.C. Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: A correlation with the levels of neuroactive steroids in the sciatic nerve. Exp Neurol 2011, 228:215-221.
29. Pesaresi M., Maschi O., Giatti S., Garcia-Segura L.M., Caruso D., Melcangi R.C. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm Behav 2010, 57:46-55.
30. Roglio I., Bianchi R., Giatti S., Cavaletti G., Caruso D., Scurati S., Crippa D., Garcia-Segura L.M., Camozzi F., Lauria G., Melcangi R.C. Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci 2007, 64:1158-1168.
31. Roglio I., Giatti S., Pesaresi M., Bianchi R., Cavaletti G., Lauria G., Garcia-Segura L.M., Melcangi R.C. Neuroactive steroids and peripheral neuropathy. Brain Res Rev 2008, 57:460-469.
32. Siriphorn A., Chompoopong S., Floyd C.L. 17beta-estradiol protects Schwann cells against H2O2-induced cytotoxicity and increases transplanted Schwann cell survival in a cervical hemicontusion spinal cord injury model. J Neurochem 2010, 115:864-872.
33. Szalat A., Raz I. Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes Obes Metab 2008, 10:1135-1156.
34. Tredici G., Tredici S., Fabbrica D., Minoia C., Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neuro Oncol 1998, 36:31-40.
35. Veiga S., Leonelli E., Beelke M., Garcia-Segura L.M., Melcangi R.C. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci Lett 2006, 402:150-153.
36. Yorek M.A., Coppey L.J., Gellett J.S., Davidson E.P., Bing X., Lund D.D., Dillon J.S. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab 2002, 283:E1067-E1075.